18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features
This study aimed to explore the correlation between imaging patterns and clinical features in patients with smoldering multiple myeloma (SMM) who simultaneously underwent 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor positron emission tomography/computed tomography (PET/CT). We retrieved and analyzed...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/8/2333 |
id |
doaj-8b43eea444ea4405ac81e5df5f899cdc |
---|---|
record_format |
Article |
spelling |
doaj-8b43eea444ea4405ac81e5df5f899cdc2020-11-25T03:24:06ZengMDPI AGCancers2072-66942020-08-01122333233310.3390/cancers1208233318F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical FeaturesXiang Zhou0Alexander Dierks1Olivia Kertels2Malte Kircher3Andreas Schirbel4Samuel Samnick5Andreas K. Buck6Sebastian Knorz7David Böckle8Lukas Scheller9Janin Messerschmidt10Mohammad Barakat11K. Martin Kortüm12Leo Rasche13Hermann Einsele14Constantin Lapa15Department of Internal Medicine II, University Hospital of Würzburg, 97080 Würzburg, GermanyDepartment of Nuclear Medicine, University Hospital of Würzburg, 97080 Würzburg, GermanyDepartment of Diagnostic and Interventional Radiology, University Hospital of Würzburg, 97080 Würzburg, GermanyDepartment of Nuclear Medicine, University Hospital of Würzburg, 97080 Würzburg, GermanyDepartment of Nuclear Medicine, University Hospital of Würzburg, 97080 Würzburg, GermanyDepartment of Nuclear Medicine, University Hospital of Würzburg, 97080 Würzburg, GermanyDepartment of Nuclear Medicine, University Hospital of Würzburg, 97080 Würzburg, GermanyDepartment of Internal Medicine II, University Hospital of Würzburg, 97080 Würzburg, GermanyDepartment of Internal Medicine II, University Hospital of Würzburg, 97080 Würzburg, GermanyDepartment of Internal Medicine II, University Hospital of Würzburg, 97080 Würzburg, GermanyDepartment of Internal Medicine II, University Hospital of Würzburg, 97080 Würzburg, GermanyDepartment of Internal Medicine II, University Hospital of Würzburg, 97080 Würzburg, GermanyDepartment of Internal Medicine II, University Hospital of Würzburg, 97080 Würzburg, GermanyDepartment of Internal Medicine II, University Hospital of Würzburg, 97080 Würzburg, GermanyDepartment of Internal Medicine II, University Hospital of Würzburg, 97080 Würzburg, GermanyDepartment of Nuclear Medicine, University Hospital of Würzburg, 97080 Würzburg, GermanyThis study aimed to explore the correlation between imaging patterns and clinical features in patients with smoldering multiple myeloma (SMM) who simultaneously underwent 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor positron emission tomography/computed tomography (PET/CT). We retrieved and analyzed clinical characteristics and PET imaging data of 10 patients with SMM. We found a significant correlation between bone marrow (BM) plasma cell (PC) infiltration and mean standardized uptake values (SUV<sub>mean</sub>) of lumbar vertebrae L2-L4 on 11C-Methionine PET/CT scans (<i>r</i> = 0.676, <i>p</i> = 0.031) and 68Ga-Pentixafor PET/CT scans (<i>r</i> = 0.839, <i>p</i> = 0.002). However, there was no significant correlation between BM involvement and SUV<sub>mean</sub> of lumbar vertebrae L2-L4 on 18F-FDG PET/CT scans (<i>r</i> = 0.558, <i>p</i> = 0.093). Similarly, mean target-to-background ratios (TBR<sub>mean</sub>) of lumbar vertebrae L2-L4 also correlated with bone marrow plasma cell (BMPC) infiltration in 11C-Methionine PET/CT (<i>r</i> = 0.789, <i>p</i> = 0.007) and 68Ga-Pentixafor PET/CT (<i>r</i> = 0.724, <i>p</i> = 0.018) PET/CT. In contrast, we did not observe a significant correlation between BMPC infiltration rate and TBR<sub>mean</sub> in 18F-FDG PET/CT (<i>r</i> = 0.355, <i>p</i> = 0.313). Additionally, on 11C-Methionine PET/CT scans, we found a significant correlation between BMPC infiltration and TBR<sub>max</sub> of lumbar vertebrae L2-L4 (<i>r</i> = 0.642, <i>p</i> = 0.045). In conclusion, 11C-Methionine and 68Ga-Pentixafor PET/CT demonstrate higher sensitivity than 18F-FDG PET/CT in detecting BM involvement in SMM.https://www.mdpi.com/2072-6694/12/8/233318F-FDG PET/CT11C-Methionine PET/CT68Ga-Pentixafor PET/CTsmoldering myeloma |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Xiang Zhou Alexander Dierks Olivia Kertels Malte Kircher Andreas Schirbel Samuel Samnick Andreas K. Buck Sebastian Knorz David Böckle Lukas Scheller Janin Messerschmidt Mohammad Barakat K. Martin Kortüm Leo Rasche Hermann Einsele Constantin Lapa |
spellingShingle |
Xiang Zhou Alexander Dierks Olivia Kertels Malte Kircher Andreas Schirbel Samuel Samnick Andreas K. Buck Sebastian Knorz David Böckle Lukas Scheller Janin Messerschmidt Mohammad Barakat K. Martin Kortüm Leo Rasche Hermann Einsele Constantin Lapa 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features Cancers 18F-FDG PET/CT 11C-Methionine PET/CT 68Ga-Pentixafor PET/CT smoldering myeloma |
author_facet |
Xiang Zhou Alexander Dierks Olivia Kertels Malte Kircher Andreas Schirbel Samuel Samnick Andreas K. Buck Sebastian Knorz David Böckle Lukas Scheller Janin Messerschmidt Mohammad Barakat K. Martin Kortüm Leo Rasche Hermann Einsele Constantin Lapa |
author_sort |
Xiang Zhou |
title |
18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features |
title_short |
18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features |
title_full |
18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features |
title_fullStr |
18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features |
title_full_unstemmed |
18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features |
title_sort |
18f-fdg, 11c-methionine, and 68ga-pentixafor pet/ct in patients with smoldering multiple myeloma: imaging pattern and clinical features |
publisher |
MDPI AG |
series |
Cancers |
issn |
2072-6694 |
publishDate |
2020-08-01 |
description |
This study aimed to explore the correlation between imaging patterns and clinical features in patients with smoldering multiple myeloma (SMM) who simultaneously underwent 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor positron emission tomography/computed tomography (PET/CT). We retrieved and analyzed clinical characteristics and PET imaging data of 10 patients with SMM. We found a significant correlation between bone marrow (BM) plasma cell (PC) infiltration and mean standardized uptake values (SUV<sub>mean</sub>) of lumbar vertebrae L2-L4 on 11C-Methionine PET/CT scans (<i>r</i> = 0.676, <i>p</i> = 0.031) and 68Ga-Pentixafor PET/CT scans (<i>r</i> = 0.839, <i>p</i> = 0.002). However, there was no significant correlation between BM involvement and SUV<sub>mean</sub> of lumbar vertebrae L2-L4 on 18F-FDG PET/CT scans (<i>r</i> = 0.558, <i>p</i> = 0.093). Similarly, mean target-to-background ratios (TBR<sub>mean</sub>) of lumbar vertebrae L2-L4 also correlated with bone marrow plasma cell (BMPC) infiltration in 11C-Methionine PET/CT (<i>r</i> = 0.789, <i>p</i> = 0.007) and 68Ga-Pentixafor PET/CT (<i>r</i> = 0.724, <i>p</i> = 0.018) PET/CT. In contrast, we did not observe a significant correlation between BMPC infiltration rate and TBR<sub>mean</sub> in 18F-FDG PET/CT (<i>r</i> = 0.355, <i>p</i> = 0.313). Additionally, on 11C-Methionine PET/CT scans, we found a significant correlation between BMPC infiltration and TBR<sub>max</sub> of lumbar vertebrae L2-L4 (<i>r</i> = 0.642, <i>p</i> = 0.045). In conclusion, 11C-Methionine and 68Ga-Pentixafor PET/CT demonstrate higher sensitivity than 18F-FDG PET/CT in detecting BM involvement in SMM. |
topic |
18F-FDG PET/CT 11C-Methionine PET/CT 68Ga-Pentixafor PET/CT smoldering myeloma |
url |
https://www.mdpi.com/2072-6694/12/8/2333 |
work_keys_str_mv |
AT xiangzhou 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures AT alexanderdierks 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures AT oliviakertels 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures AT maltekircher 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures AT andreasschirbel 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures AT samuelsamnick 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures AT andreaskbuck 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures AT sebastianknorz 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures AT davidbockle 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures AT lukasscheller 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures AT janinmesserschmidt 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures AT mohammadbarakat 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures AT kmartinkortum 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures AT leorasche 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures AT hermanneinsele 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures AT constantinlapa 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures |
_version_ |
1724603380578385920 |